[ad_1] Revenue of KRW95.4bn, operating profit of KRW42.4bn, net income of KRW37bn… 17%, 51.6%, and 72.7,%, respectively, year-on-year growth With solid performance in global markets such as Asia-Pacific and Europe, botulinum toxin and HA filler sales […]
